Highly conserved protective epitopes on influenza B viruses

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• Influenza A virus research has advanced universal vaccine strategies.
• Influenza B viruses, with distinct lineages, pose a significant public health challenge.
• Effective treatments and vaccines for influenza B are critically needed.

Purpose of the Study:

• To identify broadly neutralizing human monoclonal antibodies against influenza B viruses.
• To evaluate the protective efficacy of these antibodies against both influenza A and B viruses.
• To inform the development of universal influenza vaccines and antibody-based therapies.

Main Methods:

• Isolation and characterization of human monoclonal antibodies (CR8033, CR8071, CR9114).
• Epitope mapping to identify binding sites on the influenza hemagglutinin (HA) protein.
• In vivo efficacy studies using mouse models challenged with lethal doses of influenza viruses.

Main Results:

• CR8033 and CR8071 recognize distinct conserved epitopes in the influenza B HA head.
• CR9114 binds a conserved epitope in the influenza HA stem.
• All three antibodies demonstrated protection against lethal challenge from both influenza A and B virus lineages in mice.

Conclusions:

• Human monoclonal antibodies CR8033, CR8071, and CR9114 provide broad protection against influenza A and B viruses.
• These antibodies target conserved epitopes, making them promising candidates for universal influenza therapeutics.
• Findings support the development of next-generation influenza vaccines and antibody-based treatments.